US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AI Healthcare

673.35

+20.533.14%

Number of Gainers:1

Number of Losers:3

Number of Flat:- -

PE:- -

High:673.81

Open:651.65

Low:647.78

Close:652.82

Volume:23.97M

Turnover:713.08M

Market Cap:21.64B

Float Cap:16.56B

Loading ...

CRISPR Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

Rothschild & Co Redburn Initiates Tempus AI at Neutral With $67 Price Target

MT Newswires Live

Beam Therapeutics’ BEAM-302 shows efficacy in Phase 1/2 AATD trial

Beam Therapeutics Presents Updated Clinical Data from the Phase 1/2 Trial of Beam-302 in Alpha-1 Antitrypsin Deficiency (Aatd) at the European Respiratory Society (Ers) Congress 2026

THOMSON REUTERS

Beam Therapeutics Presents Updated Clinical Data from the Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the European Respiratory Society (ERS) Congress 2026

Tempus AI CEO Lefkofsky to Speak at Morgan Stanley Global Healthcare Conference

The Cancer Vaccine Gold Rush Has Begun. so Has the Race for Picks and Shovels - Heard on the Street

Tempus AI Director David R. Epstein Sells 250 Shares Worth $16,387.50

CRISPR Therapeutics (CRSP) Extends CTX310 Durability, Is The Stock Still Cheap?

Simply Wall St.

Recursion Pharma Director Blake Borgeson Disposes of 30,000 Shares Valued at $100,200

Top AI Healthcare Stocks For September 2026

Simply Wall St.

Tempus AI initiated with an Overweight at Cantor Fitzgerald

Tempus AI Director Nadja West Sells 3,000 Shares Worth $207,000

Investors Shrug Off Good News for Heart Patients from New Meds

Tempus AI Raised to Overweight from Neutral by Piper Sandler

Tempus AI Shares up 3% After Piper Sandler Raises to Overweight from Neutral

THOMSON REUTERS

Press Release: Beam Therapeutics Appoints Eric Foster as Chief Commercial Officer

Piper Sandler Upgrades Tempus AI to Overweight From Neutral, Adjusts PT to $76 From $56

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM) and Assembly Biosciences (ASMB)

Tempus AI, Inc. : Piper Sandler Raises to Overweight from Neutral; Raises Target Price to $76 from $56

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/BK4611/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BK4611","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4611\",,,,,undefined,":{"symbol":"BK4611","market":"US","secType":"PLATE","nameCN":"AI Healthcare","latestPrice":673.3496,"timestamp":1789502399999,"preClose":652.8213,"halted":0,"volume":23969674,"delay":0,"changeRate":0.031446,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":20.52832,"latestTime":"09-15 16:00:00 EDT","open":651.65485,"high":673.80505,"low":647.7801,"amount":713081456.799267,"amplitude":0.039865,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789545600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.73455,"peRate":-15.074117,"turnoverRate":0.029157,"increases":1,"decrements":3,"flats":0,"marketCap":21638108544,"floatMarketCap":16560695424},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4611\",,,,,undefined,":{"symbol":"BK4611","high":673.80505,"amplitude":0.039865,"preClose":652.8213,"low":647.7801,"pbRate":"4.73455","latestPrice":673.3496,"volume":23969674,"delay":0,"open":651.65485,"prevYearClose":658.3995,"prevWeekClose":628.2648,"prevMonthClose":691.9381,"prevQuarterClose":681.0329,"fiveDayClose":680.5368,"twentyDayClose":612.7481,"sixtyDayClose":639.5679,"secType":"PLATE","market":"US","turnoverRate":0.029157,"peRate":-15.074117,"marketCap":21638108544,"floatMarketCap":16560695424,"timestamp":1789502399999,"nameCN":"AI Healthcare"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4611\",,,,undefined,":{"bkCode":"BK4611","up":1,"down":3,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4611\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665378198","title":"CRISPR Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2665378198","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665378198?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:30","pubTimestamp":1788870600,"startTime":"0","endTime":"0","summary":"ZUG, Switzerland and BOSTON, Sept.  08, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today announced that members of its senior management team will present at the Morgan Stanley 24th A","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/08/3357662/0/en/crispr-therapeutics-to-present-at-the-morgan-stanley-24th-annual-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4556","LU0128526141.USD","BK4588","BK4137","LU1861558580.USD","LABU","XBI","BK4581","LU0029874061.USD","LU1861559042.SGD","SYNB","BK4585","BK4611","HCSG","XLV","ARKG","CRSP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665321422","title":"Rothschild & Co Redburn Initiates Tempus AI at Neutral With $67 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2665321422","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665321422?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:12","pubTimestamp":1788862369,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) has an average rating of overweight and mean price target of $66.75, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4611","LU1861559042.SGD","LU1861558580.USD","TEM","TEMC","ARKG","BK4613","TEMT","BK4121","HEAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665775321","title":"Beam Therapeutics’ BEAM-302 shows efficacy in Phase 1/2 AATD trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665775321","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665775321?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:10","pubTimestamp":1788862245,"startTime":"0","endTime":"0","summary":"Beam Therapeutics (BEAM) announced updated clinical data from the Phase 1/2 trial evaluating BEAM-302 for alpha-1 antitrypsin deficiency, or AATD. ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beam-therapeutics-beam-302-shows-efficacy-in-phase-1-2-aatd-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beam-therapeutics-beam-302-shows-efficacy-in-phase-1-2-aatd-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861558580.USD","BK4539","BK4588","BK4611","BK4139","BK4007","LU1861559042.SGD","BK4535","LENZ","BK4505","BK4585","BEAM","BK4556"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665290223","title":"Beam Therapeutics Presents Updated Clinical Data from the Phase 1/2 Trial of Beam-302 in Alpha-1 Antitrypsin Deficiency (Aatd) at the European Respiratory Society (Ers) Congress 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2665290223","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665290223?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:00","pubTimestamp":1788861601,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA4DNXZ2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4556","BK4139","BK4611","LU1861558580.USD","LU1861559042.SGD","BK4585","BK4535","BK4505","BEAM","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665432460","title":"Beam Therapeutics Presents Updated Clinical Data from the Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the European Respiratory Society (ERS) Congress 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2665432460","media":"GlobeNewswire","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665432460?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:00","pubTimestamp":1788861600,"startTime":"0","endTime":"0","summary":"BEAM-302 Continues to Demonstrate Potential as One-time Treatment for Both Lung and Liver Manifestations of AATD, with AAT Protein Production Under Normal Physiological Control With Up to 18 Months Fo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/08/3357432/0/en/beam-therapeutics-presents-updated-clinical-data-from-the-phase-1-2-trial-of-beam-302-in-alpha-1-antitrypsin-deficiency-aatd-at-the-european-respiratory-society-ers-congress-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4007","EPV","BK4535","BK4505","LU1861559042.SGD","IDNA","BK4539","BK4556","BK4611","BK4139","LU1878469433.USD","ALT","BK4585","BEAM","PRTO","LU1861558580.USD","BK4599","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664334854","title":"Tempus AI CEO Lefkofsky to Speak at Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664334854","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664334854?lang=en_us&edition=fundamental","pubTime":"2026-09-04 20:30","pubTimestamp":1788525028,"startTime":"0","endTime":"0","summary":"Tempus AI CEO Lefkofsky to speak at Morgan Stanley Global Healthcare ConferenceTempus AI CEO Eric Lefkofsky will join a fireside chat at Morgan Stanley’s 24th Annual Global Healthcare Conference on Se","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL5LrmbK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEMT","TEM","ARKG","LU1861558580.USD","LU1861559042.SGD","HEAL","TEMC","BK4613","BK4611","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664333870","title":"The Cancer Vaccine Gold Rush Has Begun. so Has the Race for Picks and Shovels - Heard on the Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2664333870","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664333870?lang=en_us&edition=fundamental","pubTime":"2026-09-04 17:30","pubTimestamp":1788514200,"startTime":"0","endTime":"0","summary":"The excitement surrounding Moderna and Merck's personalized mRNA cancer vaccine added more than $50 billion in combined market value for the two drug companies. But it is also creating a gold rush in ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEAL","PSNL","TEMT","LU1861558580.USD","ARKG","BK4611","TEM","BK4121","LU1861559042.SGD","TEMC","BK4613"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664809740","title":"Tempus AI Director David R. Epstein Sells 250 Shares Worth $16,387.50","url":"https://stock-news.laohu8.com/highlight/detail?id=2664809740","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664809740?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:06","pubTimestamp":1788465961,"startTime":"0","endTime":"0","summary":"Tempus AI director David R. Epstein sells 250 shares worth $16,387.50Tempus AI director David R. Epstein sold 250 shares of Class A common stock on Sept. 1, 2026 at USD 65.55.He held 30,844 shares fol","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL1WGVhM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Tempus AI Director David R. Epstein Sells 250 Shares Worth $16,387.50","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEAL","BK4121","LU1861559042.SGD","BK4613","LU1861558580.USD","TEMC","BK4611","TEM","ARKG","TEMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664826961","title":"CRISPR Therapeutics (CRSP) Extends CTX310 Durability, Is The Stock Still Cheap?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664826961","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664826961?lang=en_us&edition=fundamental","pubTime":"2026-09-03 10:26","pubTimestamp":1788402388,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics (CRSP) is back in focus after new Phase 1a durability data for CTX310, its in vivo ANGPTL3 gene editing therapy, highlighted sustained lipid reductions one year after a single infusion.\nAt a share price of $56.92, CRISPR Therapeutics has had a mixed year, with a 30 day share price return of 14.83% and a year to date share price return of 5.86%, while the 1 year total shareholder return of 7.44% suggests that momentum has been improving recently as investors react to the...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crsp/crispr-therapeutics/news/crispr-therapeutics-crsp-extends-ctx310-durability-is-the-st","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crsp/crispr-therapeutics/news/crispr-therapeutics-crsp-extends-ctx310-durability-is-the-st","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","SYNB","LU1861559042.SGD","BK4556","DCF","BK4588","SPHQ","BK4611","LU1861558580.USD","ARKG","BK4139","CRSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664423048","title":"Recursion Pharma Director Blake Borgeson Disposes of 30,000 Shares Valued at $100,200","url":"https://stock-news.laohu8.com/highlight/detail?id=2664423048","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664423048?lang=en_us&edition=fundamental","pubTime":"2026-09-03 07:27","pubTimestamp":1788391639,"startTime":"0","endTime":"0","summary":"Recursion Pharma director Blake Borgeson disposes of 30,000 shares valued at $100,200Recursion Pharmaceuticals director Blake Borgeson sold 30,000 Class A common shares on Sept. 1, 2026 at $3.34.Direc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDLbkJccF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Recursion Pharma Director Blake Borgeson Disposes of 30,000 Shares Valued at $100,200","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4611","BK4539","BK4548","BK4609","BK4139","RXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664843951","title":"Top AI Healthcare Stocks For September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2664843951","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664843951?lang=en_us&edition=fundamental","pubTime":"2026-09-02 23:20","pubTimestamp":1788362427,"startTime":"0","endTime":"0","summary":"Oil prices linked to US Iran risks are feeding into higher inflation expectations and government bond yields. That puts pressure on healthcare budgets and insurance costs, which makes smarter, more efficient care especially valuable. Artificial intelligence in healthcare targets that problem by using data, automation and remote monitoring to do more with less. This article walks through 3 stocks from our AI healthcare screener that illustrate how that theme is playing out.\nThe three stocks...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/162270-main-header/1756254067137","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/162270-main-header/1756254067137"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-pfe/pfizer/news/top-ai-healthcare-stocks-for-september-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-pfe/pfizer/news/top-ai-healthcare-stocks-for-september-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BDGV0183.EUR","LU1506573853.SGD","LU0985481810.HKD","LU0976567544.SGD","LU0006306889.USD","LU0170899867.USD","MDT","LU1861558580.USD","LU1894683264.USD","LU2112291526.USD","LU0225284248.USD","IE0002270589.USD","SG9999003800.SGD","SG9999001176.SGD","LU1983299246.USD","LU1894683348.USD","TEMC","LU2468319806.SGD","BK4007","LU1989764664.SGD","LU0321505868.SGD","TEMT","LU0106261372.USD","LU0225771236.USD","LU2271345857.HKD","BK4534","LU2023251221.USD","LU1244550221.USD","BK4588","SG9999002224.SGD","BK4585","LU0234572021.USD","LU0211326755.USD","LU1883839398.USD","SG9999001176.USD","LU2089984988.USD","PFE","SG9999011175.SGD","BK4566","LU0265550946.USD","BK4550","BK4581","BK4568","SG9999013999.USD","LU0314106906.USD","LU2596442595.SGD","LU1244550577.SGD","LU0122379950.USD","LU1116320737.USD","BK4082","LU0162691827.USD","LU0265550359.USD","LU2028103732.USD","BK4533","LU0158827948.USD","IE00BBT3K403.USD","LU0868494617.USD","BK4121","LU0496365809.HKD","IE00B3T34201.USD","LU1291159041.SGD","LU1066051498.USD","LU2111349929.HKD","LU1057294990.SGD","LU2089283258.USD","LU0158827781.USD","LU1244550494.USD","IE00BQXX3D17.EUR","HEAL","IE000M9KFDE8.USD","LU1571399168.USD","IE00BLSP4452.SGD","IE00BVYPNW00.USD","IE00BQXX3C00.GBP","LU0070302665.USD","IE00BGHQF631.EUR","SGXZ57979304.SGD","IE00B42XCP33.USD","LU0432979614.USD","LU1989764748.USD","IE00BVYPNV92.GBP","LU1066053197.SGD","BK4613","LU1989771016.USD","BK4592","LU0320765489.SGD","LU0306807586.USD","LU0321505439.SGD","IE00BQXX3F31.USD","TEM","LU1861559042.SGD","LU0211331839.USD","OZEM","ARKG","IE00BLSP4239.USD","LU0072461881.USD","LU0211326839.USD","IE00B3PB1722.GBP","LU0306806265.USD","BK4599","LU0289739699.SGD","LU0058720904.USD","LU1061106388.HKD","SG9999002232.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU1023059063.AUD","LU0456855351.SGD","LU1116320901.HKD","BK4611","IE00BFXG1179.USD","LU0208291251.USD","LU2089284900.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664813511","title":"Tempus AI initiated with an Overweight at Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2664813511","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664813511?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:10","pubTimestamp":1788343813,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald initiated coverage of Tempus AI (TEM) with an Overweight rating and $80 price target Published first on TheFly – the ultimate sou...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-initiated-with-an-overweight-at-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-initiated-with-an-overweight-at-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861559042.SGD","TEM","BK4611","TEMT","BK4613","LU1861558580.USD","ARKG","HEAL","TEMC","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664869837","title":"Tempus AI Director Nadja West Sells 3,000 Shares Worth $207,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2664869837","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664869837?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:16","pubTimestamp":1788293761,"startTime":"0","endTime":"0","summary":"Tempus AI director Nadja West sells 3,000 shares worth $207,000Tempus AI director Nadja West sold 3,000 shares of Class A common stock on Aug. 28, 2026.Sale priced at USD 69 per share.West held 31,981","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL7Zft1X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Tempus AI Director Nadja West Sells 3,000 Shares Worth $207,000","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEMC","HEAL","LU1861558580.USD","TEM","BK4613","ARKG","BK4611","BK4121","TEMT","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664866385","title":"Investors Shrug Off Good News for Heart Patients from New Meds","url":"https://stock-news.laohu8.com/highlight/detail?id=2664866385","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664866385?lang=en_us&edition=fundamental","pubTime":"2026-09-02 03:27","pubTimestamp":1788290820,"startTime":"0","endTime":"0","summary":"This year's run in drug stocks gained vigor from new treatments for heart attacks and strokes. Maybe some of those stocks are losing wind.At this past weekend's congress of the European Society of Car","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","BK4588","IBBQ","BK4556","IE00BFTCPJ56.SGD","BK4533","IE00B4R5TH58.HKD","BK4534","LU1861559042.SGD","ISBC","LU2468319806.SGD","BK4211","BK4611","IE00B2B36J28.USD","LU0868494617.USD","LU1983299246.USD","LU0122379950.USD","PBE","IBB","BK4581","AMGN","LU1057294990.SGD","BK4139","PJP","LU0109394709.USD","TBXU","CRSP","IE0009355771.USD","BK4599","LU1023059063.AUD","BIB","LU0889565916.HKD","LU0289739699.SGD","ARKG","LU0058720904.USD","IE00BJT1NW94.SGD","LU0320765992.SGD","LU2112291526.USD","LU2242646821.SGD","BK4585","IE00BJJMRZ35.SGD","LU1571399168.USD","SG9999001440.SGD","BK4566","LU2242652126.USD","LU1061106388.HKD","BBH","LU1861558580.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664868767","title":"Tempus AI Raised to Overweight from Neutral by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2664868767","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664868767?lang=en_us&edition=fundamental","pubTime":"2026-09-02 00:58","pubTimestamp":1788281880,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TEM/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM","HEAL","LU1861559042.SGD","TEMC","BK4121","BK4613","TEMT","LU1861558580.USD","ARKG","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664854953","title":"Tempus AI Shares up 3% After Piper Sandler Raises to Overweight from Neutral","url":"https://stock-news.laohu8.com/highlight/detail?id=2664854953","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664854953?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:35","pubTimestamp":1788269741,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4N44T19R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1861559042.SGD","HEAL","ARKG","BK4613","TEM","TEMT","BK4611","LU1861558580.USD","TEMC","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664853155","title":"Press Release: Beam Therapeutics Appoints Eric Foster as Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2664853155","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664853155?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:00","pubTimestamp":1788260400,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the app","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861559042.SGD","BK4556","BK4611","BK4588","BK4007","LU1861558580.USD","BK4539","BK4505","BK4535","BK4139","LENZ","BEAM","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664085891","title":"Piper Sandler Upgrades Tempus AI to Overweight From Neutral, Adjusts PT to $76 From $56","url":"https://stock-news.laohu8.com/highlight/detail?id=2664085891","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664085891?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:22","pubTimestamp":1788258126,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) has an average rating of overweight and mean price target of $65.79, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HEAL","BK4613","LU1861559042.SGD","TEMC","LU1861558580.USD","BK4121","TEMT","BK4611","ARKG","TEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664837781","title":"Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM) and Assembly Biosciences (ASMB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664837781","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664837781?lang=en_us&edition=fundamental","pubTime":"2026-09-01 17:20","pubTimestamp":1788254408,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Tempus AI, Inc. Class A (TEM) and Assembly Bioscienc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-tempus-ai-inc-class-a-tem-and-assembly-biosciences-asmb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-tempus-ai-inc-class-a-tem-and-assembly-biosciences-asmb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ASMB","LU1861558580.USD","HEAL","TEMC","LU1861559042.SGD","ARKG","TEMT","BK4613","BK4139","BK4611","TEM","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664744839","title":"Tempus AI, Inc. : Piper Sandler Raises to Overweight from Neutral; Raises Target Price to $76 from $56","url":"https://stock-news.laohu8.com/highlight/detail?id=2664744839","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664744839?lang=en_us&edition=fundamental","pubTime":"2026-09-01 15:33","pubTimestamp":1788248000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44T0BL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4613","TEMT","HEAL","BK4121","LU1861558580.USD","TEMC","LU1861559042.SGD","BK4611","TEM","ARKG"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":41,"code":"91000000","status":"200"}]}}